Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization.
We describe a case of type 2 coronary artery perforation in a 73-year-old man undergoing coronary artery rotablation and stenting with abciximab therapy. The coronary artery perforation was successfully treated by coil embolization with Trufill pushable coils made from platinum alloy and synthetic fibers to promote maximum thrombogenicity.
Assali
A R
AR
Cardiology Division, University of Texas Medical School and Hermann Hospital, Houston, Texas 77225, USA.
Moustapha
A
A
Sdringola
S
S
Rihner
M
M
Smalling
R W
RW
D000077284:Abciximab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017225:Atherectomy, Coronary / Q000009:adverse effects*; D003327:Coronary Disease / Q000628:therapy*; D003331:Coronary Vessels / Q000293:injuries*; D004621:Embolization, Therapeutic; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008297:Male; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000627:therapeutic use*; D012421:Rupture; D015607:Stents
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab